CMI Media Group just leveled up its data game.
The healthcare-focused media agency, part of WPP, has announced the appointment of Andy Shaughnessy as Senior Vice President of Data Analytics on its Customer Insights & Analytics team. The move underscores CMI’s continued push to transform complex healthcare data into actionable intelligence across online and offline channels.
Shaughnessy, a 15-year veteran of pharma analytics, brings a potent mix of omnichannel strategy, digital analytics, and organizational leadership to the role. He’ll now lead and grow a team of data specialists tasked with turning media noise into meaningful signals for pharma and life sciences brands navigating today’s high-stakes, highly regulated environment.
“Andy’s superpower is making data accessible and understandable to everyone,” said Leanne Smith, EVP, Data Strategy and Governance at CMI Media Group. “He’s succeeded on both the agency and client sides—exactly the perspective we need to keep delivering next-level value to our clients.”
A Track Record of Impact
Shaughnessy is no stranger to recognition. He’s earned accolades that include:
- Best Analytics Team award from the Digital Analytics Association (2020)
- Runner-Up in 2021
- A Global Recognition Award from GSK three years running (2018–2020)
- The Shire CEO Award in 2014
But beyond trophies, Shaughnessy has been lauded for his ability to bridge the operational and strategic sides of analytics, translating data into insights that actually move the needle for healthcare clients.
His new role at CMI Media Group puts him at the intersection of data governance, analytics innovation, and customer experience, helping the agency’s pharma clients meet rising expectations for speed, efficiency, and personalization.
Why It Matters
Healthcare marketing isn’t just regulated—it’s often labyrinthine. Brands are under constant pressure to reach precise audiences with messages that are compliant, personalized, and measurable. CMI Media Group has long been a leader in navigating these complexities, and Shaughnessy’s appointment reinforces its commitment to doing so through advanced analytics and smart data activation.
As real-world evidence, HCP engagement, and patient experience continue to shape pharma strategy, having a data leader who can see the full picture—and make it clear to stakeholders—has become a critical differentiator.
